Cargando…
ODP366 Copeptin Improves Prediction of Treatment Response in Children With Monosymptomatic Nocturnal Enuresis
BACKGROUND: Monosymptomatic nocturnal enuresis, bedwetting of children older than 5 years, affects 10% of children, and increases psychosocial burden. Monosymptomatic nocturnal enuresiscan be treated with DDAVP, a vasopressin analogue. Not all children respond to DDAVP treatment, and no reliable tre...
Autores principales: | Sailer, Clara O, Gaisl, Odile C, Beglinger, Svetlana, Sommer-Joergensen, Vivienne, Frech-Dörfler, Martina, Christ-Crain, Mirjam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625509/ http://dx.doi.org/10.1210/jendso/bvac150.1074 |
Ejemplares similares
-
ODP313 Glucagon-Stimulated Copeptin Measurements in the Differential Diagnosis of Diabetes Insipidus: A Double-Blind Randomized Placebo-Controlled Study
por: Atila, Cihan, et al.
Publicado: (2022) -
Validity of Different Copeptin Assays in the Differential Diagnosis of the Polyuria-Polydipsia Syndrome
por: Sailer, Clara Odilia, et al.
Publicado: (2021) -
Is copeptin a reliable biomarker of primary monosymptomatic nocturnal enuresis?
por: Szymanik-Grzelak, Hanna, et al.
Publicado: (2019) -
MON-441 Copeptin Response to Acute Hypoglycemia in Children and Adolescents
por: Drummond, Juliana, et al.
Publicado: (2019) -
OR20-06 Diagnosing Central Diabetes Insipidus Using Copeptin Upon Hypertonic Saline Versus Arginine Stimulation
por: Refardt, Julie, et al.
Publicado: (2023)